To demonstrate the induction of T2D, steatosis, and NASH and the effects of the VDAC1-based peptide, R-Tf-D-LP4, we first analyzed the livers for several characteristic parameters of these pathological states (Figure 1). Here, DLGAP4 is linked to metabolic dysfunction-associated steatohepatitis.